Cargando…
P941: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH LENALIDOMIDE PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-6 ARM-A INTERIM ANALYSIS
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430153/ http://dx.doi.org/10.1097/01.HS9.0000846632.03623.af |
_version_ | 1784779674776240128 |
---|---|
author | Quach, H. Gironella, M. Lee, C. Popat, R. Cannell, P. Kasinathan, R. S. Chopra, B. Rogers, R. Ferron-Brady, G. Shafi-Harji, S. Patel, N. Opalinska, J. Gupta, I. Augustson, B. |
author_facet | Quach, H. Gironella, M. Lee, C. Popat, R. Cannell, P. Kasinathan, R. S. Chopra, B. Rogers, R. Ferron-Brady, G. Shafi-Harji, S. Patel, N. Opalinska, J. Gupta, I. Augustson, B. |
author_sort | Quach, H. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9430153 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-94301532022-08-31 P941: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH LENALIDOMIDE PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-6 ARM-A INTERIM ANALYSIS Quach, H. Gironella, M. Lee, C. Popat, R. Cannell, P. Kasinathan, R. S. Chopra, B. Rogers, R. Ferron-Brady, G. Shafi-Harji, S. Patel, N. Opalinska, J. Gupta, I. Augustson, B. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430153/ http://dx.doi.org/10.1097/01.HS9.0000846632.03623.af Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Quach, H. Gironella, M. Lee, C. Popat, R. Cannell, P. Kasinathan, R. S. Chopra, B. Rogers, R. Ferron-Brady, G. Shafi-Harji, S. Patel, N. Opalinska, J. Gupta, I. Augustson, B. P941: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH LENALIDOMIDE PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-6 ARM-A INTERIM ANALYSIS |
title | P941: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH LENALIDOMIDE PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-6 ARM-A INTERIM ANALYSIS |
title_full | P941: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH LENALIDOMIDE PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-6 ARM-A INTERIM ANALYSIS |
title_fullStr | P941: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH LENALIDOMIDE PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-6 ARM-A INTERIM ANALYSIS |
title_full_unstemmed | P941: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH LENALIDOMIDE PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-6 ARM-A INTERIM ANALYSIS |
title_short | P941: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH LENALIDOMIDE PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-6 ARM-A INTERIM ANALYSIS |
title_sort | p941: safety and clinical activity of belantamab mafodotin with lenalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma (rrmm): dreamm-6 arm-a interim analysis |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430153/ http://dx.doi.org/10.1097/01.HS9.0000846632.03623.af |
work_keys_str_mv | AT quachh p941safetyandclinicalactivityofbelantamabmafodotinwithlenalidomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm6armainterimanalysis AT gironellam p941safetyandclinicalactivityofbelantamabmafodotinwithlenalidomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm6armainterimanalysis AT leec p941safetyandclinicalactivityofbelantamabmafodotinwithlenalidomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm6armainterimanalysis AT popatr p941safetyandclinicalactivityofbelantamabmafodotinwithlenalidomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm6armainterimanalysis AT cannellp p941safetyandclinicalactivityofbelantamabmafodotinwithlenalidomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm6armainterimanalysis AT kasinathanrs p941safetyandclinicalactivityofbelantamabmafodotinwithlenalidomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm6armainterimanalysis AT choprab p941safetyandclinicalactivityofbelantamabmafodotinwithlenalidomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm6armainterimanalysis AT rogersr p941safetyandclinicalactivityofbelantamabmafodotinwithlenalidomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm6armainterimanalysis AT ferronbradyg p941safetyandclinicalactivityofbelantamabmafodotinwithlenalidomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm6armainterimanalysis AT shafiharjis p941safetyandclinicalactivityofbelantamabmafodotinwithlenalidomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm6armainterimanalysis AT pateln p941safetyandclinicalactivityofbelantamabmafodotinwithlenalidomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm6armainterimanalysis AT opalinskaj p941safetyandclinicalactivityofbelantamabmafodotinwithlenalidomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm6armainterimanalysis AT guptai p941safetyandclinicalactivityofbelantamabmafodotinwithlenalidomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm6armainterimanalysis AT augustsonb p941safetyandclinicalactivityofbelantamabmafodotinwithlenalidomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm6armainterimanalysis |